ABSTRACT Early detection of Parkinson's disease (PD) is critically important because it can increase patient quality of life and save treatment costs. An innovative approach for early detection of PD is to use nonwearable sensors that are capable of capturing skeletal joint data. This article evaluates the cost-effectiveness of this sensor-based intervention considering the quality-adjusted life years (QALYs) and the associated costs. The results indicate that the intervention would be cost-effective if devices were deployed for community health screening in public places such as health fairs and pharmacies.

中文翻译：

---

评估通过创新技术早期检测帕金森病的成本效益

摘要 帕金森病（PD）的早期发现至关重要，因为它可以提高患者的生活质量并节省治疗费用。早期检测帕金森病的一种创新方法是使用能够捕获骨骼关节数据的非穿戴式传感器。本文考虑了质量调整生命年 (QALY) 和相关成本，评估了这种基于传感器的干预措施的成本效益。结果表明，如果在健康博览会和药房等公共场所部署社区健康筛查设备，干预措施将具有成本效益。